Taysha Gene Therapies

Taysha Gene Therapies(TSHA)

DALLAS, TX
Biotechnology
WebsiteLinkedInCareers Page

Focus: Adeno-associated virus gene therapies

Taysha Gene Therapies is a life sciences company focused on Adeno-associated virus gene therapies.

Gene Therapy
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

N/A
Clinical Trials (1)
NCT05277363A Study of the Natural Course of SURF1 Deficiency
N/A
Phase 1/2
Clinical Trials (1)
NCT04798235First-in-Human Study of TSHA-101 Gene Therapy for Treatment of Infantile Onset GM2 Gangliosidosis
Phase 1/2
Phase 1/2
Clinical Trials (1)
NCT06152237Safety and Efficacy of TSHA-102 in Pediatric Females With Rett Syndrome (REVEAL Pediatric Study)
Phase 1/2
Phase 3
Clinical Trials (1)
NCT05606614A Phase 1/2/3 Study of TSHA-102 Gene Therapy in Females With Rett Syndrome (REVEAL Pivotal Study)
Phase 3

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 4 clinical trials
SEC Filings: 2 available

Financials (FY2024)

Revenue
$15M518%
R&D Spend
$57M(367%)38%
Net Income
-$112M
Cash
$144M
Source: SEC 10-K Filing

Hiring Trend

Stable
0
Open Roles
+0
Added
-0
Filled/Removed

Based on last 3 crawl cycles